Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Hi-Tech Pharmacal Co Inc HITK

Healthcare Drug Manufacturers - Specialty & Generic
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:HITK)

Keller Rohrback L.L.P. Announces Investigation Regarding Weight-Loss and Workout Supplements Containing Potentially Dangerous Amounts of Amphetamine-Like Chemical BMPEA

Business Wire April 8, 2015

Akorn Completes Acquisition of Hi-Tech Pharmacal

Business Wire April 17, 2014

Repligen Corporation Set to Join the S&P SmallCap 600

PR Newswire April 15, 2014

Akorn Receives FTC Clearance for Hi-Tech Pharmacal Acquisition

Business Wire April 14, 2014

Hi-Tech Pharmacal Reports Sales of $59.9 Million for the Third Quarter Ended January 31, 2014

Business Wire March 11, 2014

Hi-Tech Pharmacal Receives Final Approval for Bromfenac Ophthalmic Solution, 0.09% (Once-A-Day)

Business Wire January 23, 2014

Hi-Tech Pharmacal Announces Settlement Regarding Texas Pricing Investigation

Business Wire December 26, 2013

Hi-Tech Pharmacal Reports Sales of $58.6 million for the Second Quarter Ended October 31, 2013

Business Wire December 10, 2013

Acquisition of Hi-Tech Pharmacal Co., Inc. (HITK) by Akorn, Inc. (AKRX) May Be Detrimental to the Interests of Hi-Tech Pharmacal Co., Inc. Shareholders

PR Newswire September 25, 2013
View More News ››

Opinion & Analysis (NDAQ:HITK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:HITK)

Q3loss/Positive news/trend reverse

Hi-Tech Pharmacal Co., Inc. announced today that the US Food and Drug Administration (FDA) has granted final approval to the Company'...
mart33 - March 24, 2008

time to join the club

eom
queenstown - September 30, 2000
View more Bullboard ››

Nicola Mining Inc

Nicola Mining Inc

Nicola Mining Inc. is a Canada-based junior mining company. The Company maintains a 100% owned mill and tailings facility ...
View More »